Unidade Local De Saude De Santo Antonio E.P.E.

Az itteni vizsgálatok

Miről szól a helyszín 128 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Tüdőrák17 vizsgálat
• Atópiás dermatitisz (ekcéma)7 vizsgálat
• Hidradenitis suppurativa7 vizsgálat
• Sclerosis multiplex (SM)7 vizsgálat
• Crohn-betegség6 vizsgálat
• Amiloidózis5 vizsgálat
• Áttétes emlőrák5 vizsgálat
• Gyomor- és nyelőcsőrák5 vizsgálat
• Colitis ulcerosa4 vizsgálat
• HIV-fertőzés4 vizsgálat
• Myasthenia gravis4 vizsgálat
• Szívelégtelenség4 vizsgálat
• és még 45

Fázis

• 3. fázis99 vizsgálat
• 2/3. fázis13 vizsgálat
• 2. fázis10 vizsgálat
• 1/2. fázis2 vizsgálat
• 4. fázis2 vizsgálat
• 1. fázis1 vizsgálat

Állapot

• Toboroz44 vizsgálat
• Lezárult34 vizsgálat
• Fut, nem toboroz31 vizsgálat
• Még nem toboroz19 vizsgálat

Fő szponzor

• Janssen Research & Development, LLC8 vizsgálat
• AbbVie7 vizsgálat
• Novartis Pharmaceuticals6 vizsgálat
• Novo Nordisk A/S6 vizsgálat
• Merck Sharp & Dohme LLC5 vizsgálat
• és még 63

Futó vizsgálatok

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Home Monitoring in eAMD Treatment

  NCT07340372· Association for Innovation and Biomedical Research on Light and Image· Forrás

  Contact: Miguel Lume

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Toboroz

  Study of an Injectable Regimen of GS-3242 with Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

  2026-526026-40-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)

  2026-525489-23-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock

  NCT07583446· 2/3. fázis· Seismic Pharmaceuticals Operations LLC· Forrás

• Toboroz

  A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

  NCT07630714· 2. fázis· AstraZeneca· Forrás

• Toboroz

  Phase 2 Randomized, Double-blind, Placebo-controlled Study of Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma

  2025-524793-42-00· 2. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  NCT07737743· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07711418· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Prilenia· Forrás

• Toboroz

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  NCT07647510· 3. fázis· Dianthus Therapeutics· Forrás

• Toboroz

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· 3. fázis· PureTech· Forrás

• Toboroz

  A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07192952· 3. fázis· Bayer· Forrás

• Toboroz

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· 3. fázis· Inhibikase Therapeutics· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  NCT07285655· 3. fázis· Liquidia Technologies, Inc.· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  NCT07202546· 2. fázis· ViiV Healthcare· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  NCT07253285· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  NCT06932562· 3. fázis· European Myeloma Network B.V.· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  NCT07155187· 2/3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  NCT07107945· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

  NCT06908304· 3. fázis· Maia Biotechnology· Forrás

• Toboroz

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· 3. fázis· Syndax Pharmaceuticals· Forrás

• Toboroz

  A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07188805· 3. fázis· Bayer· Forrás

• Toboroz

  Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.

  2023-508547-51-00· 3. fázis· Inmunotek S.L.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

  NCT06804811· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT07007065· 3. fázis· AbbVie· Forrás

• Toboroz

  Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  NCT06659445· 2. fázis· ONL Therapeutics· Forrás

• Toboroz

  A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  NCT06405087· 3. fázis· Takeda· Forrás

• Toboroz

  Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

  NCT06899126· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

  NCT07220564· 1. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hidradenitis suppurativa

  2025-520564-17-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Toboroz

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  2024-513613-12-00· 1/2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Adult Participants with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  2024-518586-10-00· 2/3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Toboroz

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  NCT06920004· 3. fázis· argenx· Forrás

• Toboroz

  Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  NCT06757634· 3. fázis· Celcuity Inc· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  NCT06976203· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Multicenter clinical trial to evaluate efficacy and safety of sublingual immunotherapy in patients allergic to house mites, with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma

  2023-505918-14-00· 3. fázis· Inmunotek S.L.· Forrás

• Toboroz

  Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

  NCT06486883· 2. fázis· MedSIR· Forrás

• Toboroz

  A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  NCT06901531· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

Showing 50 of 94.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák10 toboroz
• Crohn-betegség5 toboroz
• Áttétes emlőrák3 toboroz
• Colitis ulcerosa3 toboroz
• Időskori makuladegeneráció3 toboroz
• Magas vérnyomás3 toboroz
• Migrén3 toboroz
• Pulmonális artériás hipertónia3 toboroz
• Szívelégtelenség3 toboroz
• 1-es típusú cukorbetegség2 toboroz
• Amiloidózis2 toboroz
• Asztma2 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• HIV-fertőzés2 toboroz
• Huntington-kór2 toboroz
• Idiopátiás tüdőfibrózis2 toboroz
• Lupus (SLE)2 toboroz
• Mielóma multiplex2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Vastagbélrák2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Alzheimer-kór1 toboroz
• Elhízás1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyermekkori daganatok1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hidradenitis suppurativa1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus vesebetegség1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Melanóma1 toboroz
• Myasthenia gravis1 toboroz
• Peripheral artery disease1 toboroz
• Petefészekrák1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Prosztatarák1 toboroz
• Sjögren-szindróma1 toboroz

Lezárt vizsgálatok

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

  2024-512505-66-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

  NCT06694805· 3. fázis· ViiV Healthcare· Forrás

• Lezárult

  A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome

  NCT06312020· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Fut, nem toboroz

  Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

  NCT06635824· 3. fázis· Genmab· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511360-87-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

  NCT06558279· 3. fázis· argenx· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· 3. fázis· Alumis Inc· Forrás

• Toboroz

  A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  NCT06311682· 3. fázis· LEO Pharma· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· 3. fázis· argenx· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.

  2024-512646-42-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Lezárult

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

  NCT05263934· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

  NCT05352815· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

  NCT05298423· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

  NCT05206513· 3. fázis· Neurocrine Biosciences· Forrás

• Lezárult

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· 3. fázis· Amgen· Forrás

• Lezárult

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

  NCT04988295· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

  NCT05117242· 2. fázis· Genmab A/S· Forrás

• Fut, nem toboroz

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

  NCT04895358· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

  NCT04458051· 3. fázis· Sanofi· Forrás

• Lezárult

  An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

  NCT04353492· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

  NCT04374136· 3. fázis· Alector LLC· Forrás

• Fut, nem toboroz

  A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

  2024-518318-25-00· 3. fázis· Alnylam Pharmaceuticals Inc.· Forrás

• Lezárult

  Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

  NCT04179175· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

  NCT03759379· 3. fázis· Alnylam Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

  NCT03653507· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Lezárult

  Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

  NCT02947347· 3. fázis· Pharmacyclics LLC.· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)

  NCT02504372· 3. fázis· Merck Sharp & Dohme LLC· Forrás